Université de Toulouse-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

    Leukemia, Vol. 37, Núm. 7, pp. 1521-1529

2021

  1. Gaia Early Data Release 3: Acceleration of the Solar System from Gaia astrometry

    Astronomy and Astrophysics, Vol. 649

  2. Gaia Early Data Release 3: Structure and properties of the Magellanic Clouds

    Astronomy and Astrophysics, Vol. 649

  3. Gaia Early Data Release 3: Summary of the contents and survey properties

    Astronomy and Astrophysics, Vol. 649

  4. Gaia Early Data Release 3: The Galactic anticentre

    Astronomy and Astrophysics, Vol. 649

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 1, pp. e30-e37

2017

  1. European surgical education and training in gynecologic oncology

    International Journal of Gynecological Cancer, Vol. 27, Núm. 4, pp. 819-825

2016

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

  2. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    The Lancet Oncology, Vol. 17, Núm. 8, pp. e328-e346

2015

  1. α-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight/obese subjects

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1851, Núm. 3, pp. 273-281